Form 4: Surgery Partners Executive Danielle Burkhalter Acquires Shares Through Restricted Stock Awards

Danielle Burkhalter, Chief Human Resources Officer at Surgery Partners, Inc., reports acquisition of common stock through restricted stock awards.

Summary

• On February 28, 2024, Danielle Burkhalter, Chief Human Resources Officer of Surgery Partners, Inc., acquired 320 shares of common stock at a price of $31.18 per share through restricted stock awards that vest in two equal annual installments.
• Additionally, Ms. Burkhalter acquired 6,414 shares of common stock at the same price through restricted stock awards that vest in three equal annual installments.
• Following these transactions, Ms. Burkhalter directly owns 37,178 shares of Surgery Partners, Inc. common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock transactions by an executive. The acquisition of shares could be interpreted as a positive sign, but it's part of a pre-determined compensation plan.

Positives

• The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.

Comparison to Industry Standards

• Executive compensation packages often include stock awards to align management's interests with those of shareholders.
• Vesting schedules for restricted stock awards are typically between two and five years, which is consistent with the vesting schedules reported in this filing.
• Similar filings can be observed across the healthcare industry for companies like HCA Healthcare (HCA) and Tenet Healthcare (THC).

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals confidence from a key executive.

Key Dates